losartan has been researched along with lead in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castro, L; De Castro-e-Silva, E; De Oliveira, IR; De Paula, S; Fregoneze, JB; Gonzalez, V; Lima, AK; Luz, CP; Marinho, CA; Nascimento, T; Oliveira, P; Santana, P; Sarmento, C | 1 |
| Alonso, MJ; Fioresi, M; Salaices, M; Simões, MR; Toscano, CM; Vassallo, DV | 1 |
2 other study(ies) available for losartan and lead
| Article | Year |
|---|---|
Central lead administration induces natriuretic and kaliuretic effects in rats.
Topics: Angiotensin II; Animals; Anti-Arrhythmia Agents; Calcium; Gadolinium; Injections, Intraventricular; Lead; Losartan; Male; Microinjections; Natriuresis; Nervous System Diseases; Potassium; Rats; Rats, Wistar; Urine | 1998 |
Sub-chronic lead exposure produces β
Topics: Animals; Arterial Pressure; Cardiovascular Diseases; Down-Regulation; Heart Rate; Hexamethonium; Hypertension; Indomethacin; Isoproterenol; Lead; Losartan; Male; Nitric Oxide; Phenylephrine; Rats; Rats, Wistar; Receptors, Adrenergic, beta-1; Risk Factors | 2017 |